Lansoprazole Capsule, Delayed Release
Product Images NDC 55111-739

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Lansoprazole (NDC 55111-739). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Dr. Reddy's Laboratories Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Container (Container)

Label for Lansoprazole delayed-release capsules, USP 15 mg by Dr. Reddy's Laboratories Limited, NDC 55111-739. The label indicates 14 capsules per package, intended as a 14-day course for treating frequent heartburn. It highlights Lansoprazole as an acid reducer and includes directions and warnings on usage, with a peel-back section for more detailed instructions.*

FDA Label Image

Containercarton (Containercarton)

Packaging label for Lansoprazole delayed-release capsules, 15 mg, by Dr. Reddy's Laboratories Limited. The label states the bottle contains 14 capsules, one 14-day course of treatment for frequent heartburn. It includes drug facts, directions for use, inactive ingredients, warnings, and contact information. The label features barcodes, Dosage form, strength, and a visual of two capsules.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.